Fluge & Mella's pre-trial study highlights life-changing potential of rituximab
Sasha gives the background and Simon gives the interpretation of the latest study from Haukeland, published today...
Discuss the article on the Forums.

Simon Wessley replies

Discussion in 'General ME/CFS News' started by maryb, Dec 12, 2012.

  1. alex3619

    alex3619 Senior Member

    Messages:
    10,696
    Likes:
    24,126
    Logan, Queensland, Australia
    One of the interesting things about evidence based medicine is the capacity to upgrade evidence. Lerner is not a properly controlled RCT, but the effect size is very large. That makes it fairly good evidence, though not perfect.
     

See more popular forum discussions.

Share This Page